Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

Online articles about alopecia areata are too hard to understand and need to be clearer.

Reducing granulosa cell pyroptosis may improve oocyte maturation in PCOS.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Abrocitinib may effectively treat Lichen Planopilaris.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

Balancing testosterone may reduce COVID-19 severity.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Ca²⁺-mediated protein citrullination controls cell growth in the CNS and may help treat brain tumors.

Alopecia is caused by various factors, and new treatments like gene editing and regenerative medicine offer hope for personalized hair regrowth solutions.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Targeting pyroptosis may offer new treatments for alopecia areata, but more research is needed.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Stress causes hair loss by disrupting hair growth cycles, and combining medical and cosmetic treatments can help manage it.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.